4h
News-Medical.Net on MSNBlood cancer patients should continue BTKi therapy during COVID-19 vaccinationBlood cancer patients who receive a type of anti-cancer therapy should continue to take the drug while having COVID-19 ...
When a child is diagnosed with type 1 diabetes, both the child and family members will need to learn how to manage their ...
The Independent on MSN29d
‘Man with the golden arm’: Grandfather whose rare blood saved millions of babies dies aged 88By donating blood over 1,100 times, James Harrison helped develop Anti-D, a life-saving treatment for newborns at risk of Rhesus disease ...
A super-resolution microscopy technique offers an unparalleled glimpse into how monoclonal antibodies bind to their targets ...
An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is ...
Not to B-negative, but your blood type could offer a clue to your risk of having a stroke before 60. “The number of people with early strokes is rising,” said Dr. Steven J. Kittner, co ...
9d
News-Medical.Net on MSNUZH researchers develop decoy molecules to restore immune defenseAn immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is caused by the body's own antibodies, which inhibit important defense ...
So far, nothing we’ve been able to create can replace blood. “Whole blood” consists of three different types of cells (red ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.
An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is caused by the body's own antibodies, which inhibit important defense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results